On May 29, 2020, Aleafia Health Inc. closed a bought deal offering of 23,000,000 units at a price of $0.65 per unit for aggregate gross proceeds of approximately $14.95 million, which includes the full exercise of the over-allotment option. Each unit consisted of one common share and one-half of one common share purchase warrant of Aleafia. Each warrant shall entitle the holder thereof to purchase one common share at an exercise price of $0.80 for a period of 36 months following the closing date.
The offering was led by Eight Capital on behalf of a syndicate of underwriters including Canaccord Genuity Corp., BMO Capital Markets, Leede Jones Gable Inc., Raymond James Ltd., Mackie Research Capital Corp. and PI Financial Corp.
Cassels acted for Eight Capital with a deal team that included Nancy Choi, Florence Lau and Heesoo Kim (Securities) and Chris Norton (Tax).